DNA Script is a pioneering company specializing in the production of nucleic acids for genomic, synthetic biology, and biopharmaceutical applications. Utilizing their innovative Enzymatic DNA Synthesis (EDS) technology, implemented on the benchtop SYNTAX instrument, DNA Script accelerates advancements in life sciences and biotechnology by enabling rapid, on-demand, and high-quality DNA synthesis. The company leverages nature's evolutionary processes to set new standards in nucleic acid assembly, significantly impacting scientific discovery and DNA/RNA production. With a strong backing from high-quality investors, DNA Script is focused on the full commercialization of its technology and products, operating from its locations in Paris and San Francisco. The organization is committed to building a talented team dedicated to unlocking the potential of 'DNA-write' and contributing to the broader biological sciences.